Hypoxia Inducible Factor Pathway Inhibitors as Anticancer Therapeutics, Sarah Zingales, S. Kaluz, D. Wang, K. Wang, E. G. Van Meir, B. Wang
Sarah Zingales

Design and Synthesis of HIF-1 Inhibitors as Anti-Cancer Therapeutics, J. N. Holmes, K. Damera, Sarah Zingales, N. S. Devi, E. G. Van Meir, B. Wang
Sarah Zingales

Design and Synthesis of HIF-1 Inhibitors as Anti-Cancer Therapeutics, J. N. Holmes, K. Damera, Sarah Zingales, N. S. Devi, E. G. Van Meir, B. Wang
Department of Chemistry and Biochemistry Faculty Presentations

Hypoxia Inducible Factor Pathway Inhibitors as Anticancer Therapeutics, Sarah Zingales, Stefan Kaluz, D. Wang, K. Wang, E. G. Van Meir, B. Wang
Department of Chemistry and Biochemistry Faculty Publications

Small Molecule Inhibitors of HIF-1 as Anti-Cancer Therapeutics, Sarah Zingales, S. Reid, Z. De los Santos, N. Devi, E. G. Van Meir, B. Wang
Sarah Zingales

Binding Model for the Interaction of Anticancer Arylsulfonamides with the p300 Transcription Cofactor, Q. Shi, S. Yin, S. Kaluz, N. Ni, N. S. Devi, J. Mun, D. Wang, K. Damera, W. Chen, Sarah Zingales, S. R. Mooring, M. M. Goodman, E. G. Van Meir, B. Wang, J. P. Snyder
Sarah Zingales

Design and Synthesis of HIF-1 Inhibitors as Anti-Cancer Therapeutics, Sarah Zingales, S. Reid, H. Dinh, N. Devi, E. G. Van Meir, B. Wang
Sarah Zingales